AzTrials
AzTrials

TIA (Transient Ischemic Attack)NCT07206433

Transient Ischemic Attack (TIA) and Spoken Language

An observational study of TIA (Transient Ischemic Attack), run by Newcastle University at 1 site in United Kingdom.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Transient Ischaemic Attack (also known as TIA or 'mini-stroke') affects about 46,000 people in the UK each year. It is assumed that people recover fully within 24 hours. However, subtle problems with speaking, and confidence with their communication skills can be long-term. Read more about this study

Who is it for?
Ages 40 to 85 yearsHealthy volunteers can take part
Conditions the study is for
TIA (Transient Ischemic Attack)
How many people
30 participants
Where
1 siteUnited Kingdom
Study dates
1 Oct 2025to 30 Jun 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: TIA group: Individuals who have had a recent single medically confirmed TIA following an in-person review at a TIA clinic. Vascular risk factor group: People aged 40-75 with vascular risk factors (e.g., hypertension, diabetes, hyperlipidemia) who receive medical treatment for these conditions and have attended a TIA clinic but were not diagnosed with a TIA. Healthy group: People aged 40-75 who have no self-reported vascular risk factors for which they take medication.

Who may be able to join

None listed.

Who cannot join

  • Younger than 40 years or older than 85 years of age.
  • English as a secondary language.
  • Neurological conditions affecting cognitive function (e.g., Parkinson's disease, dementia, stroke).
  • Self-reported, pre-existing speech or cognitive problems, developmental or acquired.
  • Demonstrate noticeable difficulties carrying out project-related tasks.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Christos Salis, PhD contact

+441912088875

christos.salis@ncl.ac.uk

Janet Webster, PhD contact

+441912085235

janet.webster@ncl.ac.uk

United Kingdom1 site
  • Newcastle University

    Newcastle upon Tyne, Tyne and Wear, NE1 7RU

    Christos Salis, PhD, +441912088875, christos.salis@newcastle.ac.uk

Other trials in United Kingdom

About this study

Official title: Identification and Perceptions of Spoken Language Abilities After Transient Ischaemic Attack (TIA): An Exploratory, Longitudinal Study

Transient Ischaemic Attack (also known as TIA or 'mini-stroke') affects about 46,000 people in the UK each year. It is assumed that people recover fully within 24 hours. However, subtle problems with speaking, and confidence with their communication skills can be long-term. This project will be the first in depth exploration of speaking abilities after recent TIA where there seemed to be a full recovery.

The researchers will look for 90 volunteers for detailed testing. Thirty people who have had a TIA for the first time. For comparisons, the researchers will also include 60 volunteers without TIA (30 treated to prevent TIA and stroke; 30 who do not receive prevention treatments).

Read more

Aims and methods:

  1. To find out if TIA makes speaking difficult. People will complete speaking tasks in a quiet place. For example, people will be asked to tell us about their weekend, what they think about climate change.
  2. To find out if people are concerned about their speech and other thinking skills after TIA. People will fill in questionnaires to help us look into these issues.
  3. To find out if speaking abilities and people's own views of their communication change over time (about three months after the TIA).

Discovering new knowledge about spoken communication after a TIA diagnosis could change the course of TIA research and care across health professions (speech-language therapy, psychology, audiology, neurology). Future studies could use speaking tasks to scrutinise further the complexity of subtle communication problems after TIA and determine which individuals are likely to have these problems. The project will raise understanding of these issues, enabling affected individuals to seek professional support. Finally, it will also guide development of new TIA recommendations and treatments for these problems thus improving people's quality of life.

Read the detailed description

Montreal Cognitive Assessment (MoCA; (Nasreddine et al., 2005): Assesses general cognitive function; reliable and valid; different versions for repeated assessment (e.g., sentence repetition "I only know that John is the one to help today"; You'll hear a list of numbers and I'd like you to repeat them in the order you heard them).

Everyday Memory Questionnaire (Sunderland et al., 1986): Self-reported measure of cognitive skills many of which are about communication, language and reading (Likert scale) (e.g., forgetting the names of friends or relatives or calling them by the wrong names; getting lost or turning in the wrong direction on a journey or walk you have often been on).

Data analyses

For aims 1 and 2, the methods of analysis for each of the outcome measures is detailed below and will be in conducted in R.

Descriptive statistics by subgroup (medians, range, inter-quartile range) will be generated for each outcome measure (speech-related [primary, secondary], Everyday Memory Questionnaire, Communication Confidence Rating Scale for Aphasia).

Kruskal-Wallis non-parametric analysis of variance will be carried out for each outcome measure (alpha level .05). Post-hoc pairwise comparisons (using Dunn's test correction for multiple comparisons) for statistically significant results. Effect sizes will also be obtained.

Communication Confidence Rating Scale for Aphasia (Cherney et al., 2011): Self-reported confidence in communication activities (Likert scale) (e.g., how confident are you about your ability to talk with people? How confident are you that people understand you when you talk?)

Connected speech assessment tasks (Whitworth et al., 2015): Assesses connected speech skills, (e.g., can you tell me what you did last weekend? Can you remember a recent celebration such as a birthday, anniversary, wedding or party that you have been to? Can you tell me about it? What do you think about global warming and why?)

For aim 3, descriptive statistics (as above) will be generated for each outcome measure non-parametric Wilcoxon tests (alpha level 0.5) will be used. Effect sizes will also be obtained. These analyses will also be carried out in R.

Keywords
TIA, Transient Ischemic Attack, speech, language
Medical subject headings
Ischemic Attack, Transient, Speech, Language

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Speech rate

    measured as number of words per minute

    Measured: From enrollment

  2. Mean length of sentence

    measured in number of words

    Measured: From enrollment

  3. Sentence complexity

    measured as number of complex sentences

    Measured: From enrollment

  4. Functional Memory Questionnaire

    Patient-reported measure of perceptions of memory, attention, language abilities;

    score range 0 to 140; higher scores mean a worse outcome

    Measured: From enrollment

  5. Communication Confidence Rating Scale for Aphasia

    Patient-reported measure of confidence of communication abilities;

    score range 0 to 600; higher scores mean worse outcome

    Measured: From enrollment

Secondary outcomes (3)
  1. Filled pause rate

    Number of filled paused (i.e., "um" "uh", "ehm") over total number of words

    Measured: From enrollment

  2. Lexical richness

    measured as number of unique words over total number of words

    Measured: From enrollment

  3. Propositional idea density

    using the Computerized Propositional Idea Density Rater - CPIDER3 - Brown et al. (2008)

    Measured: From enrollment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Oct 2025
  2. Study start1 Oct 2025 (estimated)
  3. Primary completion30 Jun 2027 (estimated)
  4. Study completion30 Jun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07206433
Sponsor's protocol ID
TIASPEECHPROTOCOL3132025
Status last verified
Apr 2025
First submitted
23 Apr 2025
Last updated
3 Oct 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of TIA (Transient Ischemic Attack), run by Newcastle University at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 3 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Christos Salis, PhD (+441912088875, christos.salis@ncl.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Speech rate (time frame: From enrollment). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in